IMMUNIC, INC. — Director's Dealing 2023

Apr 27, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUNIC, INC. (IMUX)
CIK: 0001280776
Period of Report: 2023-04-26

Reporting Person: Rudick Richard Alan (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-04-26	Stock Option	$1.63	A	32000	Acquired	2033-04-26	Common Stock (32000)	Direct

Footnotes

F1: The options vest in monthly increments over a period of three years from the grant date.